Ying Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ying Zhang has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
Haodong Li
4 shared publicationsJie Liu
4 shared publicationsManyu Gong
4 shared publicationsYanwei Zhang
4 shared publications- Baofeng Yang
Harbin Medical University
3 shared publications Dongping Liu
3 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 732-745
In situ self-assembled stimulus-responsive and conductive hydrogel modulate myocardial infarction inflammatory homeostasis via PPARα/NFκB signaling and enhance the therapeutic efficacy of hiPSC-CMs
Stem cell therapies are emerging as promising strategies for repair after myocardial infarction (MI), but the repair efficacy is limited by the poor cardiac microenvironment represented by the inflammatory response, as well as oxidative stress, and adverse electrical coupling. Here, we developed an injectable supramolecular hydrogel (HCPA) that modulates the infarct microenvironment and accelerates myocardial repair by encapsulating human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CMs). HCPA hydrogel not only exhibited excellent reactive oxygen species (ROS) response in order to minimize oxidative stress but also possessed desirable electrical conductivity for the reintegration of electrical impulses. Critically, RNA sequencing demonstrated that the PPARα/NFκB pathway contributed significantly to the HCPA hydrogel-promoted macrophage polarization from M1-type to M2-type, thus alleviating inflammatory responses. HCPA hydrogel harboring hiPSC-CMs increased retention of hiPSC-CMs and improved cardiac function in MI mice. This study represents a new integrated therapeutic option for MI and provides insights for the development of novel biomaterials in the field of tissue engineering.
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 732-745
Open AccessIn situ self-assembled stimulus-responsive and conductive hydrogel modulate myocardial infarction inflammatory homeostasis via PPARα/NFκB signaling and enhance the therapeutic efficacy of hiPSC-CMs
Stem cell therapies are emerging as promising strategies for repair after myocardial infarction (MI), but the repair efficacy is limited by the poor cardiac microenvironment represented by the inflammatory response, as well as oxidative stress, and adverse electrical coupling. Here, we developed an injectable supramolecular hydrogel (HCPA) that modulates the infarct microenvironment and accelerates myocardial repair by encapsulating human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CMs). HCPA hydrogel not only exhibited excellent reactive oxygen species (ROS) response in order to minimize oxidative stress but also possessed desirable electrical conductivity for the reintegration of electrical impulses. Critically, RNA sequencing demonstrated that the PPARα/NFκB pathway contributed significantly to the HCPA hydrogel-promoted macrophage polarization from M1-type to M2-type, thus alleviating inflammatory responses. HCPA hydrogel harboring hiPSC-CMs increased retention of hiPSC-CMs and improved cardiac function in MI mice. This study represents a new integrated therapeutic option for MI and provides insights for the development of novel biomaterials in the field of tissue engineering.
- Open Access
- 6 July 2026
- Published by Elsevier in Journal of Advanced Research
MDH1 K298 succinylation stabilizes redox homeostasis to protect against cardiac ferroptosis in ischemia–reperfusion injury
- 6 July 2026
- Published by Elsevier in Journal of Advanced Research
Open AccessMDH1 K298 succinylation stabilizes redox homeostasis to protect against cardiac ferroptosis in ischemia–reperfusion injury
- Open Access
- 15 July 2025
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (9) , 4789-4806
Palmitoylated SARM1 targeting P4HA1 promotes collagen deposition and myocardial fibrosis: A new target for anti-myocardial fibrosis
- 15 July 2025
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 15 (9) , 4789-4806
Open AccessPalmitoylated SARM1 targeting P4HA1 promotes collagen deposition and myocardial fibrosis: A new target for anti-myocardial fibrosis
- 6 November 2022
- Published by Elsevier in Vascular Pharmacology
- Vol. 147, 107126
NAD+ attenuates cardiac injury after myocardial infarction in diabetic mice through regulating alternative splicing of VEGF in macrophages
- 6 November 2022
- Published by Elsevier in Vascular Pharmacology
- Vol. 147, 107126
NAD+ attenuates cardiac injury after myocardial infarction in diabetic mice through regulating alternative splicing of VEGF in macrophages